StonvexLoading…
StonvexCore line items from RDVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $90.25M | $75.19M | $60.20M | $53.32M |
Operating Income | $13.14M | $7.92M | $2.50M | $361.00K |
Net Income | $13.15M | $7.00M | $13.53M | $616.00K |
EPS (Diluted) | $0.91 | $0.50 | $0.96 | $0.04 |
Total Assets | $112.01M | $98.53M | $92.99M | $77.41M |
Total Liabilities | $11.09M | $11.90M | $6.88M | $6.32M |
Cash & Equivalents | $43.56M | $36.50M | $32.03M | $31.81M |
Free Cash Flow OCF − CapEx | $28.79M | $23.79M | $14.95M | $12.09M |
Shares Outstanding | 14.15M | 13.94M | 13.97M | 13.96M |